Matrix Metalloproteinase 9 Expression by Immunohistochemistry in Intratumor Macrophages as Tumor-Associated Macrophage Marker of Papillary Thyroid Carcinoma
Open Access
- 29 September 2022
- journal article
- research article
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 15 (3) , 1671-1676
Abstract
Papillary thyroid carcinoma (PTC) comprises 80% of well-differentiated thyroid carcinomas. PTC progression is determined by a variety of biological markers, some of which are connected to the activities of Tumor-Associated Macrophage (TAM). TAM activity is difficult to observe using simply traditional histology techniques. Matrix Metalloproteinase 9 (MMP-9) is an important marker for identifying the development of PTC. However, no studies have linked the expression of MMP-9 to intratumoral macrophages in PTC patients, demonstrating that these macrophages are TAMs implicated in the development of PTC. Through MMP-9 expression on intratumor macrophages, the objective of this work was to evaluate TAM's involvement as a progression determinant of PTC. This cross-sectional study analyzed 40 samples, which included 21 PTC patients with intratumor macrophages and 19 PTC instances without intratumor macrophages. Medical records and paraffin blocks of the Biomedical Laboratory, Faculty of Medicine and Healthcare, Warmadewa University were used to collect samples. The proportion of MMP-9 expression in both groups' macrophages was then determined by immunohistochemical labeling and evaluated using Chi-Square with a significance level (a) of p<0.05. The results revealed a statistically significant difference in MMP-9 expression between the PTC groups with and without intratumor macrophages, with p-value = 0.001 (p<0.05) and OR = 11.9.Keywords
This publication has 21 references indexed in Scilit:
- Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in LeukaemiasCancers, 2014
- Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltrationCroatian Medical Journal, 2014
- Gelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionCancers, 2014
- The Expression of Tumor-Associated Macrophages in Papillary Thyroid CarcinomaEndocrinology and Metabolism, 2013
- Expression and clinical significance of matrix metalloproteinase 9 (MMP9) papillary thyroid carcinomasAfrican Journal of Pharmacy and Pharmacology, 2012
- Follicular Variant of Papillary Thyroid CancerEncapsulated, Nonencapsulated, and Diffuse: Distinct Biologic and Clinical EntitiesJAMA Otolaryngology–Head & Neck Surgery, 2012
- Recent Advances in Follicular Variant of Papillary Thyroid CarcinomaAmerican Chinese Journal of Medicine and Science, 2012
- Histological subtype is the most important determinant of survival in metastatic papillary thyroid cancerThyroid Research, 2011
- Papillary thyroid carcinoma: an updateLaboratory Investigation, 2011
- Biological role of matrix metalloproteinases: a critical balanceEuropean Respiratory Journal, 2010